Â鶹ѧÉú¾«Æ·°æ

Whitney K. Hendrickson
Rating: 5.0 of 5
( out of 119 reviews )

Whitney K. Hendrickson, MD

Languages spoken: English

Clinical Locations

Primary Location

University of Utah Hospital

Urogynecology, Area E
50 N Medical Dr
Salt Lake City , UT 84132
801-213-2995

  • Dr. Whitney Hendrickson is a specialized urogynecologist dedicated to women's health. She focuses on both medical and surgical treatments for pelvic organ prolapse, urinary incontinence, and fecal incontinence. She offers minimally invasive robotic surgery for prolapse and sacral neuromodulation for conditions like urgency incontinence, fecal incontinence, and urinary retention.

    Dr. Hendrickson, who works in the Division of Urogynecology and Pelvic Reconstructive Surgery at the Â鶹ѧÉú¾«Æ·°æ, is currently accepting new patients with pelvic floor disorders.

    Dr. Hendrickson earned her medical degree from the University of Massachusetts and completed her Obstetrics & Gynecology residency at UC San Diego. She then pursued advanced training with a fellowship in Urogynecology and Pelvic Reconstructive Surgery (formerly called Female Pelvic Medicine and Reconstructive Surgery) at Duke University.

    In addition to her clinical work, Dr. Hendrickson is involved in quality improvement, clinical research, and medical education. She is the founder and chair of the Gynecology Quality Improvement and Patient Safety Committee, aimed at improving surgical outcomes for all gynecologic surgeries at the University of Utah.

    Her research is aimed at improving treatment outcomes for pelvic floor disorders, mostly focused on overactive bladder and lower urinary tract symptoms. She has developed tools to help both patients and clinicians make informed treatment decisions, particularly in managing urgency urinary incontinence and predicting post-surgical complications.

    As a Eunice Kennedy Shriver National Institute of Child Health and Human Development Women’s Reproductive Health Research (WRHR) K12 scholar, she is studying the outcomes of treatments for urgency urinary incontinence, including OnabotulinumtoxinA (BOTOX®) and sacral neuromodulation (SNM) to understand who will respond best to which therapy. She is also involved in medical student and resident education mostly focusing on surgical didactics.

    Specialties

    Board Certification

    American Board of Obstetrics & Gynecology (Female Pelvic Medicine & Reconstructive Surg)
    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)

    Patient Rating

    Rating: 5.0 out of 5
    5.0 /5
    ( out of 119 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety. For the convenience of our visitors, some patient comments have been translated from their original language into English while preserving their original meaning as accurately as possible. Patients are de-identified for confidentiality and patient privacy.

    September 18, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    She is very nice and patient with all of my questions.

    September 17, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    She is very knowledgeable, caring, genuine and her presence put you at ease and makes you feel in a safe place.

    September 17, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Dr. Hendrickson is an amazing doctor. She has an excellent bedside manner and takes the time to explain everything. She also answered any questions that I had. I am very satisfied with the care that I received from her and her staff.

    September 16, 2025
    SOUTH JORDAN HEALTH CENTER
    Rating: 5 out of 5

    A great provider with a very pleasing personality and knowledge of the problems.

    September 10, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Excellent service [TRANSLATED]

    September 06, 2025
    SOUTH JORDAN HEALTH CENTER
    Rating: 5 out of 5

    Dr Hendrickson is both very professional and kind. I am so grateful for her getting my life back. What a great asset she is to the U of U. I would absolutely recommend her to any woman needing a urogynecologist.

    August 09, 2025
    SOUTH JORDAN HEALTH CENTER
    Rating: 5 out of 5

    Dr. Hendricksen is fantastic. She is knowledgeable, friendly, and answers any questions I may have.

    August 03, 2025
    UNIVERSITY HOSPITAL
    Rating: 5 out of 5

    Excellent Doctor. Listen to everything I had to say. Explained everything about surgery and after care.

    July 19, 2025
    UNIVERSITY HOSPITAL
    Rating: 3 out of 5

    Provisea excellent care in every way.

    See More Patient Comments

  • Dr. Whitney Hendrickson is a specialized urogynecologist dedicated to women's health. She focuses on both medical and surgical treatments for pelvic organ prolapse, urinary incontinence, and fecal incontinence. She offers minimally invasive robotic surgery for prolapse and sacral neuromodulation for conditions like urgency incontinence, fecal incontinence, and urinary retention.

    Dr. Hendrickson, who works in the Division of Urogynecology and Pelvic Reconstructive Surgery at the Â鶹ѧÉú¾«Æ·°æ, is currently accepting new patients with pelvic floor disorders.

    Dr. Hendrickson earned her medical degree from the University of Massachusetts and completed her Obstetrics & Gynecology residency at UC San Diego. She then pursued advanced training with a fellowship in Urogynecology and Pelvic Reconstructive Surgery (formerly called Female Pelvic Medicine and Reconstructive Surgery) at Duke University.

    In addition to her clinical work, Dr. Hendrickson is involved in quality improvement, clinical research, and medical education. She is the founder and chair of the Gynecology Quality Improvement and Patient Safety Committee, aimed at improving surgical outcomes for all gynecologic surgeries at the University of Utah.

    Her research is aimed at improving treatment outcomes for pelvic floor disorders, mostly focused on overactive bladder and lower urinary tract symptoms. She has developed tools to help both patients and clinicians make informed treatment decisions, particularly in managing urgency urinary incontinence and predicting post-surgical complications.

    As a Eunice Kennedy Shriver National Institute of Child Health and Human Development Women’s Reproductive Health Research (WRHR) K12 scholar, she is studying the outcomes of treatments for urgency urinary incontinence, including OnabotulinumtoxinA (BOTOX®) and sacral neuromodulation (SNM) to understand who will respond best to which therapy. She is also involved in medical student and resident education mostly focusing on surgical didactics.

    Board Certification and Academic Information

    Academic Departments Obstetrics & Gynecology -Assistant Professor (Clinical)
    Academic Divisions Urogynecology
    Board Certification
    American Board of Obstetrics & Gynecology (Female Pelvic Medicine & Reconstructive Surg)
    American Board of Obstetrics & Gynecology (Obstetrics & Gynecology)

    Education history

    Fellowship Urogynecology and Reconstructive Pelvic Surgery (Formerly Female Pelvic Medicine and Reconstructive Surgery) - Duke University Medical Center Fellow
    Internship/Residency Gynecology & Reproductive Science - University of California, San Diego School of Medicine Administrative Chief Resident
    Residency Integrative Medicine Elective - University of Arizona College of Medicine Visiting Resident
    Internship/Residency Obstetrics & Gynecology - University of California San Diego Medical Center Intern/Resident
    Professional Medical Medicine; concentration in Multicultural Pathways - University of Massachusetts Medical School M.D.
    Undergraduate Molecular Biology & Biochemistry (High honors, cum laude) - Middlebury College B.A.

    Selected Publications

    Journal Article

    1. Hendrickson WK, Allshouse A, Nygaard IE, Swenson CW (2025). ASSOCIATION BETWEEN ENLARGED GENITAL HIATUS AND PROLAPSE WITH OVERACTIVE BLADDER 1 YEAR AFTER VAGINAL DELIVERY. Am J Obstet Gynecol, S0002-9378(25)00226-1. ()
    2. Hendrickson WK, Zhang C, Hokanson JA, Nygaard IE, Presson AP (2024). Predicting success using response after lead implantation with sacral neuromodulation for urgency incontinence. Neurourol Urodyn, 43(8), 1776-1783. ()
    3. Hendrickson WK, Zhang C, Jelovsek JE, Nygaard IE, Presson AP (2023). Longitudinal Fluctuations in Treatment Response After OnabotulinumToxinA and Sacral Neuromodulation for Refractory Urgency Incontinence. J Urol, 211(1), 134-143. ()
    4. Hendrickson WK, Zhang C, Jelovsek JE, Nygaard IE, Presson AP (2024). Reply by Authors. J Urol, 211(1), 142-143. ()
    5. Hendrickson WK, Allshouse AA, Nygaard IE, Swenson CW (2023). Overactive Bladder in Late Pregnancy to 1 Year After First Vaginal Delivery. Urogynecology (Phila), 30(4), 433-442. ()
    6. Lai HH, Wiseman JB, Helmuth ME, Smith AR, Amundsen CL, Cameron AP, Glaser AP, Hendrickson WK, Kirkali Z, Kenton K (2022). Phenotyping of Urinary Urgency Patients without Urgency Incontinence, and Their Comparison to Urgency Incontinence Patients: Findings from the LURN Study. J Urol, 209(1), 233-242. ()
    7. Kowalski JT, Wiseman JB, Smith AR, Helmuth ME, Cameron A, DeLancey JOL, Hendrickson WK, Jelovsek JE, Kirby A, Kreder K, Lai HH, Mueller M, Siddiqui N, Bradley CS (2022). Natural history of lower urinary tract symptoms in treatment-seeking women with pelvic organ prolapse; the Symptoms of Lower Urinary Tract Dysfunction Research Network (LURN). Am J Obstet Gynecol, 227(6), 875.e1-875.e12. ()
    8. Hendrickson WK, Xie G, Rahn DD, Amundsen CL, Hokanson JA, Bradley M, Smith AL, Sung VW, Visco AG, Luo S, Jelovsek JE (2021). Predicting outcomes after intradetrusor onabotulinumtoxina for non-neurogenic urgency incontinence in women. Neurourol Urodyn, 41(1), 432-447. ()
    9. Hendrickson WK, Havrilesky L, Siddiqui NY (2021). Cost-effectiveness of bacteriuria screening before urogynecologic surgery. Am J Obstet Gynecol, 226, 831.e1-831.e12. ()
    10. Harvie HS, Sung VW, Neuwahl SJ, Honeycutt AA, Meyer I, Chermansky CJ, Menefee S, Hendrickson WK, Dunivan GC, Mazloomdoost D, Bass SJ, Gantz MG, Eunice Kennedy Shriver National Institute of Child Health and Human Development Pelvic Floor Disorders Network (2021). Cost-effectiveness of behavioral and pelvic floor muscle therapy combined with midurethral sling surgery vs surgery alone among women with mixed urinary incontinence: results of the Effects of Surgical Treatment Enhanced With Exercise for Mixed Urinary Incontinence randomized trial. Am J Obstet Gynecol, 225(6), 651.e1-651.e26. ()
    11. Hendrickson WK, Amundsen CL, Rahn DD, Meyer I, Bradley MS, Smith AL, Myers DL, Jelovsek JE, Lukacz ES (2021). Comparison of 100 U With 200 U of Intradetrusor OnabotulinumToxinA for Nonneurogenic Urgency Incontinence. Female Pelvic Med Reconstr Surg, 27(3), 140-146. ()
    12. Hendrickson WK, Amundsen CL (2021). Sacral neuromodulation: troubleshooting needle placement. Int Urogynecol J, 32, 2549-2551. ()
    13. Hendrickson WK, Amundsen CL (2020). Sacral neuromodulation: sacral anatomy and optimal lead placement. Int Urogynecol J, 32, 2545-2547. ()
    14. Hendrickson WK, Amundsen CL (2019). 2019 Update on pelvic floor dysfunction: review of fecal incontinence treatments. 31(9), 23, 24, 26-30.
    15. Downey JS, Mashburn-Warren L, Ayala EA, Senadheera DB, Hendrickson WK, McCall LW, Sweet JG, Cvitkovitch DG, Spatafora GA, Goodman SD (2014). In vitro manganese-dependent cross-talk between Streptococcus mutans VicK and GcrR: implications for overlapping stress response pathways. PLoS One, 9(12), e115975. ()
    16. Flavin R, Pettersson A, Hendrickson WK, Fiorentino M, Finn S, Kunz L, Judson GL, Lis R, Bailey D, Fiore C, Nuttall E, Martin NE, Stack E, Penney KL, Rider JR, Sinnott J, Sweeney C, Sesso HD, Fall K, Giovannucci E, Kantoff P, Stampfer M, Loda M, Mucci LA (2014). SPINK1 protein expression and prostate cancer progression. Clin Cancer Res, 20(18), 4904-11. ()
    17. Kasperzyk JL, Finn SP, Flavin R, Fiorentino M, Lis R, Hendrickson WK, Clinton SK, Sesso HD, Giovannucci EL, Stampfer MJ, Loda M, Mucci LA (2013). Prostate-specific membrane antigen protein expression in tumor tissue and risk of lethal prostate cancer. Cancer Epidemiol Biomarkers Prev, 22(12), 2354-63. ()
    18. Hendrickson WK, Flavin R, Kasperzyk JL, Fiorentino M, Fang F, Lis R, Fiore C, Penney KL, Ma J, Kantoff PW, Stampfer MJ, Loda M, Mucci LA, Giovannucci E (2011). Vitamin D receptor protein expression in tumor tissue and prostate cancer progression. J Clin Oncol, 29(17), 2378-85. ()
    19. Fang F, Kasperzyk JL, Shui I, Hendrickson W, Hollis BW, Fall K, Ma J, Gaziano JM, Stampfer MJ, Mucci LA, Giovannucci E (2011). Prediagnostic plasma vitamin D metabolites and mortality among patients with prostate cancer. PLoS One, 6(4), e18625. ()

    Book Chapter

    1. Whitney K Hendrickson and Matthew D Barber (). Chapter 19: Surgical Treatment of Anterior Vaginal Wall Prolpase. In Matthew D. Barber; Mark D. Walters; Mickey M. Karram; Catherine Bradley (Ed.), Walters & Karram Urogynecology and Reconstructive Pelvic Surgery (6th). Elsevier.
    2. Hendrickson WK and MD Barber (2023). Chapter 8.2 Anterior Vaginal Wall Prolapse. In Linda Cardozo, M.D. and David R. Staskin, M.D (Eds.), Textbook of Female Urology and Urogynecology: Surgical Perspectives (5th ed). CRC Press.

    Letter

    1. Swenson CW, Hendrickson WK, Allshouse AA, Nygaard IE (2024). Older maternal age at first vaginal delivery is associated with increased genital hiatus size at 1 year postpartum. [Letter to the editor]. Am J Obstet Gynecol, 230(6), e110-e112. ()

  • News & Podcasts

    Podcasts